Financials
- Market Capitalization 3.69 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.29
Relación precio/flujo de caja
-439.06
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4798 | APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 0.77 USD | +4.05% | -1.28% | -38.40% | -41.22% | 11.62 M USD | ||
| 4896 | KAPA Kairos Pharma, Ltd. Common Stock | 0.34 USD | 0.00% | -8.11% | -24.44% | -41.38% | 7.28 M USD | ||
| 5062 | DCOY Decoy Therapeutics Inc. - Common Stock | 5.80 USD | -0.68% | -17.38% | -9.38% | +617.11% | 3.09 M USD | ||
| 5102 | VIVS VivoSim Labs, Inc. - Common Stock | 0.81 USD | 0.00% | -10.99% | -30.77% | -57.59% | 2.11 M USD |